Menu Search
Equities

Amplifon SpA

AMP:MIL

Amplifon SpA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)23.61
  • Today's Change0.35 / 1.50%
  • Shares traded119.08k
  • 1 Year change-16.69%
  • Beta0.5787
Data delayed at least 15 minutes, as of Nov 22 2024 11:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy3
Outperform5
Hold7
Sell1
Strong Sell0

Share price forecast in EUR

The 15 analysts offering 12 month price targets for Amplifon SpA have a median target of 33.00, with a high estimate of 38.00 and a low estimate of 27.40. The median estimate represents a 41.87% increase from the last price of 23.26.
High63.4%38.00
Med41.9%33.00
Low17.8%27.40

Dividends in EUR

In 2023, Amplifon SpA reported a dividend of 0.29 EUR, equaling last years dividend. The 15 analysts covering the company expect dividends of 0.29 EUR for the upcoming fiscal year, an increase of 1.03%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in EUR

On Oct 30, 2024, Amplifon SpA reported 3rd quarter 2024 earnings of 0.08 per share.
The next earnings announcement is expected on Mar 05, 2025.
Average growth rate+19.07%
Amplifon SpA reported annual 2023 earnings of 0.689 per share on Mar 07, 2024.
Average growth rate+0.59%
More ▼

Revenue history & estimates in EUR

Amplifon S.p.A. had 3rd quarter 2024 revenues of 267.58m. This missed the 570.29m consensus estimate of the 7 analysts following the company. This was 50.47% below the prior year's 3rd quarter results.
Average growth rate-10.34%
Amplifon S.p.A. had revenues for the full year 2023 of 2.26bn. This was 6.65% above the prior year's results.
Average growth rate+7.62%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.